IP Library Granted Patent US 7,691,414
Granted Patent B2
US 7,691,414 · App. 10/979,506 · Granted Apr 6, 2010

Membrane scaffold proteins

Assignee: The Board of Trustees of the University of Illinois
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,691,414
App. No.
10/979,506
Granted
Apr 6, 2010
Kind
B2
Abstract

Membrane proteins are difficult to express in recombinant form, purify, and characterize, at least in part due to their hydrophobic or partially hydrophobic properties. Membrane scaffold proteins (MSP) assemble with target membrane or other hydrophobic or partially hydrophobic proteins or membrane fragments to form soluble nanoscale particles which preserve their native structure and function; they are improved over liposomes and detergent micelles. In the presence of phospholipid, MSPs form nanoscopic phospholipid bilayer disks, with the MSP stabilizing the particle at the perimeter of the bilayer domain. The particle bilayer structure allows manipulation of incorporated proteins in solution or on solid supports, including for use with such surface-sensitive techniques as scanning probe microscopy or surface plasmon resonance. The nanoscale particles facilitate pharmaceutical and biological research, structure/function correlation, structure determination, bioseparation, and drug discovery.

Claims (10)

1. A nanoscale particle comprising a non-naturally occurring amphipathic membrane scaffold protein having at least one alpha helix, and at least one additional hydrophobic or partially hydrophobic protein, and further comprising a phospholipid or a mixture of phospholipids, wherein said non-naturally occurring membrane scaffold protein, in an aqueous environment, self-assembles in the presence of phospholipids or in the presence of a mixture of phospholipids, into a nanoscale particle between 5 nm and 500 nm in diameter, wherein said membrane scaffold protein is a derivative or a truncated form of human apolipoprotein A1, is amphipathic and wherein said membrane scaffold protein forms at least one alpha helix, and lacks the N-terminal globular domain of in human apolipoprotein A1 (amino acids 8-50 of SEQ ID NO:2), and wherein the additional hydrophobic or partially hydrophobic protein is covalently linked to said membrane scaffold protein.

2. The nanoscale particle of claim 1 , wherein the nanoscale particle is 5 nm to 10 nm in diameter.

3. The nanoscale particle of claim 1 , wherein the nanoscale particle is from 5 nm to 50 nm in diameter.

4. The nanoscale particle of claim 1 , wherein the additional hydrophobic or partially hydrophobic membrane protein has a hydrophobic interaction with said phospholipid or mixture of phospholipids.

5. The nanoscale particle of claim 1 , wherein the additional hydrophobic or partially hydrophobic protein is a cytochrome P450, bacteriorhodopsin, tissue factor or a cytochrome.

6. A nanoscale particle comprising a non-naturally occurring amphipathic membrane scaffold protein having at least one alpha helix and at least one additional hydrophobic or partially hydrophobic membrane protein, and further comprising a phospholipid or a mixture of phospholipids, wherein said non-naturally occurring membrane scaffold protein, in an aqueous environment, self-assembles in the presence of phospholipids or in the presence of a mixture of phospholipids, into a nanoscale particle between 5 nm and 500 nm in diameter, wherein the membrane scaffold protein consists of an amino acid sequence selected from the group consisting of SEQ ID NO: 6, SEQ ID NO:9, SEQ ID NO:17, amino acids 13-414 of SEQ ID NO:17, SEQ ID NO:19, amino acids 13-422 of SEQ ID NO:19, SEQ ID NO:23, amino acids 13-168 of SEQ ID NO:23, SEQ ID NO:29, amino acids 13-168 of SEQ ID NO:29, SEQ ID NO:43, amino acids 13-201 of SEQ ID NO:43, SEQ ID NO:44, amino acids 13-201 of SEQ ID NO:44, SEQ ID NO:45, and amino acids 13-392 of SEQ ID NO:45 and wherein native structure and activity of the hydrophobic or partially hydrophobic membrane protein is maintained in the particle.

7. The nanoscale particle of claim 6 , wherein the nanoscale particle is 5 nm to 10 nm in diameter.

8. The nanoscale particle of claim 6 , wherein the nanoscale particle is from 5 nm to 50 nm in diameter.

9. The nanoscale particle of claim 6 , wherein the additional hydrophobic or partially hydrophobic membrane protein has a hydrophobic interaction with said phospholipid or mixture of phospholipids.

10. A nanoscale particle comprising a non-naturally occurring amphipathic membrane scaffold protein having at least one alpha helix and at least one additional hydrophobic or partially hydrophobic membrane protein, and further comprising a phospholipid or a mixture of phospholipids, wherein said non-naturally occurring membrane scaffold protein, in an aqueous environment, self-assembles in the presence of phospholipids or in the presence of a mixture of phospholipids, into a nanoscale particle between 5 nm and 500 nm in diameter, wherein the membrane scaffold protein consists of a sequence selected from the group consisting of SEQ ID NO: 6, SEQ ID NO:9, SEQ ID NO:17, amino acids 13-414 of SEQ ID NO:17, SEQ ID NO:19, amino acids 13-422 of SEQ ID NO:19, SEQ ID NO:23, amino acids 13-168 of SEQ ID NO:23, SEQ ID NO:29, amino acids 13-168 of SEQ ID NO:29, SEQ ID NO:43, amino acids 13-201 of SEQ ID NO:43, SEQ ID NO:44, amino acids 13-201 of SEQ ID NO:44, SEQ ID NO:45, and amino acids 13-392 of SEQ ID NO:45 and wherein the additional hydrophobic or partially hydrophobic protein is a cytochrome P450, bacteriorhodopsin, tissue factor or a cytochrome.

Assignments (3)
CONFIRMATORY LICENSE Recorded Aug 17, 2010
From: UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 024838/0468 →
CONFIRMATORY LICENSE Recorded Oct 29, 2008
From: UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 021751/0718 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 25, 2006
From: SLIGAR, STEPHEN G.; BAYBURT, TIMOTHY H.
To: THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS
Reel/Frame 017062/0655 →
Continuity (3)
Continuation 0999008700 · Nov 20, 2001
Provisional Application 6025223300 · Nov 20, 2000
Related Publication 20050152984A1 · Jul 14, 2005